Stocks rise as vaccine, merger news draw focus


Stocks rose Monday as investors considered positive developments around a coronavirus vaccine candidate, and eyed a flurry of newly announced mergers and acquisitions among major companies. Tech shares shook off last week’s jitters and led the S&P 500 higher.

AZN) announced over the weekend that its late-stage Covid-19 vaccine trials with the University of Oxford had resumed, after safety concerns over a suspected adverse reaction from a participant had led the company to pause trials temporarily a week earlier. Shares rose about a 0.5% in early trading.” data-reactid=”17″AstraZeneca (AZN) announced over the weekend that its late-stage Covid-19 vaccine trials with the University of Oxford had resumed, after safety concerns over a suspected adverse reaction from a participant had led the company to pause trials temporarily a week earlier. Shares rose about a 0.5% in early trading.

ORCL) shares rose after the company on Monday confirmed reports that it was included in a proposal for TikTok that the social media owner’s ByteDance submitted to the US Treasury Department over the weekend. This followed reports from multiple news outlets that the tech company landed a partnership with TikTok’s US business unit, edging out Microsoft (MSFT), which had previously been viewed as the frontrunner for a tie-up with the fast-growing social media company. Microsoft shares ticked lower in pre-market trading, extending losses from Friday.” data-reactid=”22″Elsewhere, Oracle (ORCL) shares rose after the company on Monday confirmed reports that it was included in a proposal for TikTok that the social media owner’s ByteDance submitted to the US Treasury Department over the weekend. This followed reports from multiple news outlets that the tech company landed a partnership with TikTok’s US business unit, edging out Microsoft (MSFT), which had previously been viewed as the frontrunner for a tie-up with the fast-growing social media company. Microsoft shares ticked lower in pre-market trading, extending losses from Friday.

“Global markets are kicking off the week on an optimistic footing, with M&A activity and vaccine developments helping to lift spirits after recent declines,” Josh Mahony, senior market analyst at IG, wrote in an email Monday.

The development between Oracle and TikTok “does help ease friction between the US and China, yet there will be questions over just how much data remains available to the main entity,” he added. “On the vaccine front, news that the AstraZeneca vaccine trial is to resume provides a significant boost after fears that complications with one participant could represent a significant hurdle to development. With Trump telling states to expect a vaccine before the election, there is a feeling that we are in the home straight in the push for an effective treatment.”

NVDA) announced it was purchasing SoftBank Group’s chip unit Arm Limited in a transaction valued at $40 billion – the largest ever in the semiconductor industry. Elsewhere, Gilead Sciences (GILD) agreed to purchase Immunomedics (IMMU) in an about $21 billion deal, adding the latter’s tumor-fighting drugs to the pharmaceutical giant’s portfolio. Shares of Gilead rose slipped 1% in early trading, while Immunomedics’ stock more than doubled.” data-reactid=”25″Other major corporations also announced massive new deals over the weekend. Chipmaker Nvidia (NVDA) announced it was purchasing SoftBank Group’s chip unit Arm Limited in a transaction valued at $40 billion – the largest ever in the semiconductor industry. Elsewhere, Gilead Sciences (GILD) agreed to purchase Immunomedics (IMMU) in an about $21 billion deal, adding the latter’s tumor-fighting drugs to the pharmaceutical giant’s portfolio. Shares of Gilead rose slipped 1% in early trading, while Immunomedics’ stock more than doubled.

GOOG, GOOGL) YouTube unit is set to launch a short-form video platform called “Shorts,” entering into direct competition with TikTok and Facebook’s (FB) newly launched “Reels” content service.” data-reactid=”30″Alphabet’s (GOOG, GOOGL) YouTube unit is set to launch a short-form video platform called “Shorts,” entering into direct competition with TikTok and Facebook’s (FB) newly launched “Reels” content service.

Alphabet said Monday. ” data-reactid=”31″The early beta version of Shorts, which will include videos 15 seconds in length or less, will be launched over the next few days in India, Alphabet said Monday.

Concerns that last week’s sharp drawdown in tech stocks will drag on may be…



Read More: Stocks rise as vaccine, merger news draw focus

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More

Privacy & Cookies Policy

Get more stuff like this
in your inbox

Subscribe to our mailing list and get interesting stuff and updates to your email inbox.

Thank you for subscribing.

Something went wrong.